September 2015
San Francisco-based biotech CytomX Theraputics has filed to raise $100 million for an initial public offering, a brief with the Securities and Exchange Commission shows . The company develops cancer immunotherapies that avoid healthy cells.
01
Sep
2015
Comments Off on San Francisco biotech CytomX files for $100 million IPO
August 2015
Biotechnology stocks are on track to beat the stock market for a remarkable fifth year straight. The largest biotech exchange-traded fund, iShares Nasdaq Biotechnology ETF (IBB), with more than $9 billion in assets, rallied an average of 36% the past five years vs. 10.4% for the SPDR S&P 500 ETF (SPY). [...]
13
Aug
2015
Comments Off on A More Viable Way To Invest In Top-Performing Biotech Stocks
TRENTON, N.J. (AP) — Early research in older adults found an experimental vaccine prevented nearly two-thirds of serious cases of a common, seasonal respiratory virus that annually kills thousands of vulnerable Americans — babies and senior...
13
Aug
2015
Comments Off on Novavax: Early study indicates its vaccine effective vs. RSV
Sorrento Therapeutics, closely allied with Patrick Soon-Shiong's fast-growing oncology drug empire, has bagged two private biotech companies, adding some CAR-T therapies to the mix.
12
Aug
2015
Comments Off on Sorrento’s biotech buyouts bag CAR-T drugs
Jeremy Levin has stepped up with a $75 million round to back Phase II work on Ovid Therapeutics' lead drug for rare brain diseases as the ex-Teva chief executes on his plan to build a pipeline of experimental drugs in neurology.
12
Aug
2015
Comments Off on Fidelity, Sanofi back $75M round for Jeremy Levin’s neurology startup
Aucun pays ne parvient à endiguer le surpoids d'une partie croissante de la population. Plutôt que de blâmer les pouvoirs publics, des scientifiques misent sur l'innovation
11
Aug
2015
Comments Off on Obésité : les biotechnologies veulent réussir là où les politiques échouent
L’été signe l’ouverture des grands chantiers pour le laboratoire français. Déjà leader reconnu dans le domaine de la prise... Sujets liés Pharmacie, Pharmacie / Biotechnologies, Sanofi, Stratégie - L'information de l'industrie
11
Aug
2015
Comments Off on Immuno-oncologie, diabétologie : les nouveaux chantiers de Sanofi
"Four years ago, the protein called CRISPR-Cas9, an enzyme that bacteria use to attack viruses that infect them, was unknown to humans. Now it is ubiquitous in science labs as the most efficient way of cutting-and-pasting DNA yet invented. "
11
Aug
2015
Comments Off on Bill Gates And 13 Other Investors Pour $120 Million Into Revolutionary Gene-Editing Startup
The higher rents rise in the Boston/Cambridge biotech hub, the hotter its rep as the go-to life sciences cluster in the U.S. A new survey from the property analysts at JLL, or Jones Lang LaSalle, ranked Beantown as the top biotech cluster in America, followed by Raleigh-Durham, San Francisco, San Diego and New York City.
10
Aug
2015
Comments Off on Biotech’s top boomtowns: Rising rents, growing salaries and larger ranks
"Un mois à peine après son entrée en Bourse, sur le marché Alternex Paris, et une levée de fonds... Articles liés Pharmacie, Pharmacie / Biotechnologies, Santé, Finances - L'information de l'industrie"
10
Aug
2015
Comments Off on Biophytis lève 6 millions d’euros un mois après son introduction en Bourse
August 2015